PATHPLORE
LIVE

Serial Number

88210692

Owner

BIODYNE CO., LTD

Attorney

Michael Park

Filing Date

Nov 29, 2018

Add to watchlist:

No watchlists yet
View on USPTO

PATHPLORE Trademark

Serial Number: 88210692 • Registration: 5993741

PATHPLORE is a trademark filed by BIODYNE CO., LTD on November 29, 2018. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

BIODYNE CO., LTD (7 trademarks)

24-4, Achasan-ro 5-gil,

Entity Type: 99

Trademark Details

Filing Date

November 29, 2018

Registration Date

February 25, 2020

Published for Opposition

December 10, 2019

Goods & Services

Computer software for processing specimen cell images for diagnosing diseases for medical purposes; software for creating and processing digital images of specimen cell for diagnosing diseases for medical purposes; neural network software for use in machine learning of diagnosing diseases based on digital images of cells for medical purposes; neural network software for use in processing of digital images of specimen cells for diagnosing diseases for medical purposes; laboratory equipment, namely, microscope slides; containers especially adapted for microscope slides; vials for laboratory use

Medical apparatus, namely, medical imaging apparatus incorporating medical imaging software for creating digital images of specimen cells, machine learning the digital image of specimen cell in neural network, and processing the digital images of specimen cells in neural networks for diagnosing diseases for medical purposes; automatic cytology analyzers for medical diagnosis; medical diagnostic saliva vials; slides for surgical use, namely, medical specimen collection slides for the collection of cells during surgery; cytology brushes; immunological analyzers, namely, immunoassay analyzers for medical diagnostic purposes; medical diagnostic instruments for microbial screening and identification; medical diagnostic apparatus for testing cells; cytological analyzers for medical diagnostic purposes; specimen production apparatus for cytological medical diagnosis; analytical medical diagnostic apparatus for use in medical analysis of cells; molecular diagnostic instruments for medical purposes for detecting cancer; medical apparatus and instruments for the clinical diagnosis of cancer; medical diagnostic instruments for in vitro diagnostic testing and analysis of exfoliated cells; analyzers for measuring, testing and analyzing blood, bodily fluids and tissue for medical diagnostic purposes; hematological analyzers for medical diagnostic uses; specimen production apparatus for hematological medical diagnosis; specimen smearing apparatus for medical diagnosis, namely, cytology apparatus and machines for use in Liquid Based Cytology (LBC); cell testing apparatus, namely, medical diagnostic apparatus for testing cells

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 25, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Feb 25, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 10, 2019 NPUB
PUBLISHED FOR OPPOSITION
Dec 10, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 20, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 6, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 31, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 31, 2019 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Oct 31, 2019 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 11, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 11, 2019 GNSL
SUSPENSION LETTER WRITTEN
Jun 11, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 5, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 5, 2019 CRFA
ASSIGNED TO LIE
Jun 4, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 30, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 3, 2019 GNRN
NON-FINAL ACTION E-MAILED
Mar 3, 2019 GNRT
NON-FINAL ACTION WRITTEN
Mar 3, 2019 CNRT
ASSIGNED TO EXAMINER
Feb 28, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 17, 2018 NWOS
NEW APPLICATION ENTERED
Dec 3, 2018 NWAP